| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.615 | 46.402 | 40.067 | 58.412 | 21.363 | 54.635 | 12.637 | 76 | 0 | 0 |
| Total Income - EUR | 48.615 | 46.402 | 40.067 | 58.412 | 21.363 | 54.635 | 12.642 | 76 | 0 | 0 |
| Total Expenses - EUR | 48.173 | 45.182 | 39.790 | 55.024 | 35.041 | 35.554 | 26.262 | 12.646 | 0 | 7.287 |
| Gross Profit/Loss - EUR | 442 | 1.219 | 277 | 3.388 | -13.678 | 19.081 | -13.620 | -12.570 | 0 | -7.287 |
| Net Profit/Loss - EUR | 245 | 966 | 187 | 2.783 | -13.891 | 18.488 | -13.747 | -12.572 | 0 | -7.287 |
| Employees | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Biovital Millenium Group Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.034 | 2.077 | 20.211 | 40.906 | 29.652 | 52.781 | 27.635 | 2.074 | 2.068 | 2.056 |
| Inventories | 2.198 | 0 | 0 | 0 | 2.615 | 1.743 | 61 | 18 | 18 | 18 |
| Receivables | 336 | -7 | 583 | 541 | 1.957 | 1.703 | 2.463 | 751 | 749 | 745 |
| Cash | 500 | 2.084 | 19.628 | 40.364 | 25.080 | 49.335 | 25.112 | 1.304 | 1.300 | 1.293 |
| Shareholders Funds | 1.044 | 1.999 | 2.152 | 4.896 | -9.090 | 9.570 | -4.388 | -16.974 | -16.923 | -24.116 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 1.990 | 78 | 18.058 | 36.009 | 38.742 | 43.210 | 32.024 | 19.048 | 18.991 | 26.172 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8220 - 8220" | |||||||||
| CAEN Financial Year |
8220
|
|||||||||
Comments - Biovital Millenium Group Srl